Pramod Thomas is a senior correspondent with Asian Media Group since 2020, bringing 19 years of journalism experience across business, politics, sports, communities, and international relations. His career spans both traditional and digital media platforms, with eight years specifically focused on digital journalism. This blend of experience positions him well to navigate the evolving media landscape and deliver content across various formats. He has worked with national and international media organisations, giving him a broad perspective on global news trends and reporting standards.
THE senior official accused of downplaying allegations of racism made by former Yorkshire cricketer Azeem Rafiq is set to return for a second stint as chairman of the financially stricken English county club.
Colin Graves, Yorkshire's chairman from 2012-2015 having first saved the club from commercial collapse in 2002, was given the go ahead to return to his old role at Headingley after members approved a special resolution at an extraordinary general meeting Today (2).
The resolution passed with 746 votes in favour, 88 per cent of the votes cast, although the ballot result is still subject to approval by the Financial Conduct Authority.
Once fully ratified, the second tranche of a personal, unsecured loan of £1 million from Graves will be advanced to the club.
“The result of the vote for the special resolution to make a number of changes to the rules of the club required in relation to a refinancing proposal from Colin Graves as set out in the notice was announced, with members voting in favour of the rule changes,” Yorkshire County Cricket Club (YCCC) said in a statement.
"I would like to express my thanks to the membership of Yorkshire County Cricket Club who have so overwhelmingly voted to ratify the board's decision to accept my offer to our great club," Graves said.
Last month the Yorkshire board, with some £15m owed to the Graves family trust and insisting several other options were unviable, told the club's members they were recommending a loan offer from Graves "having exhausted all other options".
Graves' return has aroused strong feelings after he gave an interview to Sky Sports last year when he said no one had reported any incidents of racism to him when he was in charge at Yorkshire, although he was aware of "a lot of banter".
The 76-year-old Graves, also a former chairman of the England and Wales Cricket Board, has since expressed "profound regret" for those remarks.
Rafiq, however, said he did not accept Graves' apology.
Afterwards, Rafiq said he had received racist messages on social media after the club's approval of a loan offer from a consortium headed by Graves.
Pakistan-born spinner Rafiq went public with allegations of racism and bullying in September 2020, related to his two spells at Yorkshire.
But current Yorkshire chairman Harry Chathli told members last Friday: "We as directors would not be discharging our duty of care if we deliberately put this club into administration just because we didn't like a personality. That cannot happen."
Rafiq went public with allegations of racism and bullying in September 2020.
His revelations led the ECB to threaten Yorkshire with the withdrawal of hosting rights for lucrative England matches at the club's Headingley headquarters in Leeds.
They also prompted the creation of an independent inquiry that found officials had failed to tackle institutional racism and sexism in English cricket.
Yorkshire were fined £400,000 and handed a 48-point deduction in the County Championship last year after an investigation into racism allegations by Rafiq.
Six former Yorkshire players were found guilty of using racist language in the Rafiq case.
But former England captain Michael Vaughan was cleared of using racist language "on the balance of probabilities" after opting to defend himself at a hearing in March last year.
Yorkshire are one of the most important clubs in English cricket history, with a record 32 outright County Championship titles and a host of England greats, including Len Hutton, Fred Trueman, Geoffrey Boycott and, more recently, Joe Root, to their credit.
The ECB warned last month it was "vital" efforts to tackle discrimination at Yorkshire continued, and that it had "significant powers which can be used to hold Yorkshire to account" if they felt this was not the case.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.